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Living in an enriched environment with complex
physical and social stimulation leads to improved
cognitive and metabolic health. In white fat, enrich-
ment induced the upregulation of the brown fat cell
fate determining gene Prdm16, brown fat-specific
markers, and genes involved in thermogenesis and
b-adrenergic signaling. Moreover, pockets of cells
with prototypical brown fat morphology and high
UCP1 levels were observed in the white fat of en-
riched mice associated with resistance to diet-
induced obesity. Hypothalamic overexpression of
BDNF reproduced the enrichment-associated acti-
vation of the brown fat gene program and lean
phenotype. Inhibition of BDNF signaling by genetic
knockout or dominant-negative trkB reversed this
phenotype. Our genetic and pharmacologic data
suggest amechanismwhereby induction of hypotha-
lamic BDNF expression in response to environmental
stimuli leads to selective sympathoneural modula-
tion of white fat to induce ‘‘browning’’ and increased
energy dissipation.
INTRODUCTION
Obesity and metabolic syndrome are rapidly becoming major
global health, social, and economic problems with substantial
morbidity and mortality (Batsis et al., 2007) highlighting the
urgent need for new therapeutic strategies. Obesity results
from chronic excess energy intake over energy expenditure
and is controlled by variable and complicated interactions
between genetic background, environmental factors, behavioral
factors, and socioeconomic status. We sought to use environ-
mental approaches to identify potential molecular therapeutic
candidates and regulation pathways. Previously, we demon-
strated that an enriched environment (EE), consisting of physi-
cally and socially more complex housing, leads to improved324 Cell Metabolism 14, 324–338, September 7, 2011 ª2011 Elseviecerebral health as defined by increased neurogenesis, enhanced
learning and memory, and resistance to external cerebral insults
(Cao et al., 2004; Young et al., 1999). Moreover, we observed
that the mice living in EE housing were leaner than those living
in standard laboratory housing although they were fed ad libitum
on identical diets. To further characterize this phenotype, we
examined the molecular and morphological features of the fat.
Two types of adipose tissue have been found in mammals, white
adipose tissue (WAT) and brown adipose tissue (BAT). WAT and
BAT are different at functional, morphological, and molecular
levels. BAT dissipates energy directly as heat through uncou-
pling fatty acid oxidation from ATP production by uncoupling
protein-1 (UCP1), is vital for the regulation of body temperature
(Enerback et al., 1997), and is also involved in the control of
body weight (Feldmann et al., 2009). BAT has recently become
a potential target for pharmacological and genetic manipulation
to treat human obesity because positron emission tomography
has provided evidence that adult humans retain metabolically
active BAT depots which can be induced in response to cold
and sympathetic nervous system (SNS) activation (Cypess
et al., 2009; van Marken Lichtenbelt et al., 2009; Virtanen et al.,
2009). WAT accumulates excess energy as triacylglycerols and
was previously viewed as a passive organ with relatively simple
functions such as energy storage, heat insulation, and mechan-
ical cushioning. However, recent developments have demon-
strated that WAT is a versatile and more complex organ with
many functions other than energy balance and thatWAT is highly
adaptive to external stimuli. Of interest, brown adipocyte-like
cells are found in WAT of rodents and humans. These cells,
with a multilocular morphology and expressing the brown adipo-
cyte-specific UCP-1, are called brown-in-white (brite) cells,
beige cells, or adaptive or recruitable brown adipocytes (Ener-
back, 2009; Petrovic et al., 2010). Although the precise origin
of these cells is not fully defined, the development of these
thermogenic-competent cells in WAT is greatly enhanced in
response to chronic cold exposure or prolonged b-adrenergic
stimulation (Cousin et al., 1992; Guerra et al., 1998; Himms-
Hagen et al., 1994), and the occurrence of these cells is associ-
ated with resistance to obesity and metabolic diseases (Ceder-
berg et al., 2001; Guerra et al., 1998; Leonardsson et al.,
2004). Here we observed a white to brown fat transformation inr Inc.
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induced obesity (DIO). Furthermore, we sought to identify
the key components of the hypothalamic-adipocyte axis regu-
lating this ‘‘browning’’ effect by pharmacological and genetic
approaches.
RESULTS
EE Decreases Adiposity
C57BL/6 mice were randomly assigned to live in either grouped
control housing or EE with larger space, running wheels, and
regularly changed toys and mazes under an ambient tempera-
ture of 22C. Both control and EE animals had free access to
normal chow diet (NCD) and water. After 4 weeks EE, the EE
mice had slightly lower body weights than control mice and
a marked reduction in WAT mass (Figure 1A). All of the WAT
pad weights were markedly decreased: inguinal WAT (IWAT)
by 46.3% ± 4.8%, epididymal WAT (EWAT) by 46.7% ± 3.7%,
and retroperitoneal WAT (RWAT) by 73.7% ± 2.5%. Magnetic
resonance imaging (MRI) showed 49.3% ± 12.8% decrease of
abdominal fat mass (Figure 1B). Since physical exercise
decreases body fat, we subjected another group of mice to
voluntary wheel running for 4 weeks. Running decreased body
weight similarly to EE mice (Figure 1A). However, the reduction
in WAT in runners was significantly less than that observed
with EE (Figure 1A, p < 0.05). Both EE and running increased
gastrocnemius mass, by 22.7% ± 3.5% and 12.8% ± 2.5%,
respectively. We traced the traveling distance of EE mice plus
the wheel running distance excluding activity within the feeding
cage (the regular mouse cage) (Cao et al., 2010). The total
distance traveled by the EE mice was 0.86 km/d more than
control mice but approximately 66% lower than runner’s average
traveling distance 2 km/d/mouse, indicating the further reduction
of adiposity was not due to greater overall motor activity in EE.
We measured the whole-body metabolism of mice after
5 weeks EE using the CLAMS for 3 days at room temperature.
No difference in oxygen consumption was found in the EE
mice compared to the control mice. However, the EE mice,
upon removal from their complex environment, showed signifi-
cantly lower physical activity in themetabolic chambers (see Fig-
ure S1A available online, p < 0.05). The change of environment
from EE to single housing in the metabolic chamber and the
impact on metabolism resulting from the coping behavior
complicates the evaluation of energy expenditure. Therefore
the data from the CLAMSmay not properly represent the energy
expenditure in the EE. In contrast to EE, wheel-running mice
showed higher physical activity in the metabolic chambers
compared to control mice, yet no significant increase in oxygen
consumption was observed (Figures S1A and S1B), further
demonstrating the limitation of CLAMS in the setting of acute
environmental changes. We then used an alternative approach
to measure metabolism for 3 hr starting immediately upon
removal from the EE cage; the EE mice showed increased basal
resting oxygen consumption at thermoneutrality (Figure 1D)
(Feldmann et al., 2009). To supplement the whole body metabo-
lism measurement, we measured the oxygen consumption of
dissected fat depots ex vivo. The EE mice showed increased
oxygen consumption in RWAT, whereas running mice showed
higher oxygen consumption in BAT (Figure 1E). In addition, theCell MeEE mice showed increased food intake (Figure 1C), indicating
that elevated energy expenditure rather than appetite suppres-
sion underlies the lean phenotype.
To further investigate the extent to which physical activity
accounts for the lean phenotype induced by EE, we analyzed
another group of mice housed in the EE cage with the running
wheel removed. In addition, instead of being housed in the
running wheel cages equipped to measure running distance in
the previous experiment, the voluntary running group in this
experiment was housed in the regular control cages with access
to the same wheels as the EE mice. We monitored body weight
closely over 9 weeks. In contrast to the 4 weeks EE with minimal
handling, the runners were the only group that showed a signifi-
cant decrease in body weight, while the body weight of EE mice
with no access to running wheels was identical to that of the
control mice (Figure 1F). However, the standard EEmice showed
the most marked reduction in adiposity, with EWAT, RWAT, and
IWAT decreased by 58.4% ± 3.6%, 70.0% ± 2.5%, and 46.5% ±
3.6%, respectively (Figure 1G). The EE no wheel mice showed
a trend toward greater IWAT and EWAT mass reduction than
the wheel running mice when fat mass was standardized to
body weight (Figure 1G), suggesting that wheel running was
not essential for the EE-induced fat mass reduction.
In order to investigate the potential mechanisms differentiating
EE- and running-induced lean phenotypes, we profiled gene
expression in the hypothalamus, one of the brain regions
involved in energy homeostasis. EE and running led to multiple
changes in the expression of genes involved in energy balance
but displayed two distinctive profiles in the whole hypothalamus
dissections after 4 weeks EE or running (Figure S1B). The hypo-
thalamus contains a number of discrete nuclei including the
arcuate (ARC), paraventricular (PVH), ventromedial (VMH),
dorsomedial (DMH), and lateral hypothalamic area (LH). We
previously observed differential gene expression profiles in the
ARC, which has traditionally been considered a primary site for
the central action of leptin on energy homeostasis (Stephens
et al., 1995), of the EE mice compared to the running mice after
4 weeks of respective housing (Cao et al., 2010). Here we
analyzed gene expression in the PVH, which was recently shown
to be not simply downstream of the ARC but an additional
primary site for a multinodal leptin/MC4R system regulating
energy homeostasis (Ghamari-Langroudi et al., 2011). After
10 weeks EE or running, we observed two qualitatively distinct
patterns in the PVH (Figure 1H). Running led to the induction of
corticotrophin-releasing hormone (CRH) accompanied by the
significant downregulation of its two receptors, Crhr1 and
Crhr2. EE showed a trend of upregulation of thyrotropin-
releasing hormone (TRH) in contrast to the trend of downregula-
tion in the running mice (Figure 1H), suggesting that the EE
and running reduce adiposity via distinct mechanisms. Thyroid
hormones increase energy expenditure via a process termed
‘‘thyroid thermogenesis’’ (Cannon and Nedergaard, 2010), and
recent findings suggest thyroid hormones affect the hypo-
thalamus and subsequently activate BAT, leading to increased
energy expenditure (Lopez et al., 2010). EE upregulated Trh
expression in the hypothalamus; however, hyperthyroidism
was not observed in mice after 9 weeks EE (serum T3, control
0.746 ± 0.025 ng/ml, EE 0.649 ± 0.036 ng/ml, p = 0.062;
T4, control 4.52 ± 0.18 mg/dl, EE 3.15 ± 0.38 mg/dl, p = 0.01;tabolism 14, 324–338, September 7, 2011 ª2011 Elsevier Inc. 325
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Figure 1. EE Decreases Adiposity of Mice Fed on NCD
(A) Four weeks of EE or wheel running decreased body weight and fat pad mass (n = 10 per group).
(B) MRI analysis of abdominal fat and lean mass (n = 5 per group). Intra-ab., intra-abdominal; Subcu., subcutaneous.
(C) EE increased food intake (n = 10 per group).
(D) EE increased basal resting oxygen consumption (n = 8 per group); *p < 0.05.
(E) EE increased oxygen consumption in RWAT ex vivo (p < 0.05 EE compared to control and running, n = 3 per group). Running increased oxygen consumption in
BAT (p < 0.05 running compared to control and EE, n = 3 per group). NRF, normalized relative fluorescence.
(F) EE and EE no wheel did not decrease body weight, whereas wheel running decreased body weight (n = 10–20 per group) *p < 0.05 for running.
(G) Fat pad mass calibrated to body weight (n = 10–19 per group).
(H) Gene expression profile of the PVH after 10 weeks respective housing (n = 5 per group). Bars not connected by same letter are significantly different. Data are
means ± SEM. See also Figure S1.
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Figure 2. EE Induces Brown Fat Molecular Features in White Fat
(A and B) Gene expression profile of RWAT (A) and BAT (B) after 4 weeks of respective housing (n = 5 per group).
(C) H&E staining and UCP1 immunohistochemistry of RWAT. Scale bar, 20 mm.
(D) Western blot of RWAT.
(E) Mitochondrial DNA content of RWAT (n = 4 per group); *p < 0.05.
(F) Gene expression profile of RWAT after 9 weeks of respective housing (n = 4 per group). Bars not connected by the same letter are significantly different.
Data are means ± SEM. See also Figure S2.
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p = 0.64).
EE Induces Brown Fat Molecular Phenotype in WAT
BAT and WAT perform opposing functions, with WAT accumu-
lating surplus energy while BAT dissipates energy as heat. We
examined the impact of EE on BAT and WAT gene expression
profiles by quantitative RT-PCR after 4 weeks of EE (Figures
2A and 2B, Figures S2A and S2B). Limited gene expression
changes were observed in BAT, with 6 out of the 19 genes
profiled showing significant change (Figure 2B, Figure S2B). In
contrast, RWAT was far more responsive to the EE, with 15 out
of the 19 genes profiled showing altered expression (Figure 2A,
Figure S2A). Prdm16 (PR-domain-containing 16), which has
been identified as a genetic switch determining the formation
and function of brown adipocytes (Seale et al., 2008) was signif-Cell Meicantly upregulated by 2.8- ± 0.8-fold in RWAT. The induction of
Prdm16 was accompanied by the robust induction of a BAT
molecular signature including Cidea (13.6- ± 1.0-fold), Elovl3
(27.4- ± 11.2-fold), Ucp1 and Ppargc1a (encoding PGC-1a), all
of which are BAT-selective markers and positively regulated by
Prdm16 (Seale et al., 2008). PGC-1a has been shown to switch
cells from energy storage to energy expenditure phenotype by
inducing mitochondrial biogenesis and genes involved in ther-
mogenesis (Puigserver et al., 1998). Data from knockout mouse
strains suggest that several transcriptional regulators, such as
RIP140 (Leonardsson et al., 2004), SRC2 (Picard et al., 2002),
Rb (Hansen et al., 2004), and Twist1 (Pan et al., 2009), control
brown adipocyte development and function, at least in part
through regulating the transcriptional activity or gene expression
of PGC-1a. This transcriptional coactivator was upregulated
4.1- ± 2.1-fold in RWAT of EE mice. BAT dissipates energy viatabolism 14, 324–338, September 7, 2011 ª2011 Elsevier Inc. 327
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This phenomenon is primarily mediated by UCP 1 (Ucp1), which
is a specific BAT marker (Nicholls and Locke, 1984). Ucp1 was
increased 27.7- ± 8.0-fold in RWAT of EEmice. Other uncoupling
proteins with a role in protection against oxidative damage,Ucp2
and Ucp3, were also upregulated. In addition, Dio2 (type 2 50 de-
iodinase) and Ppard, both involved in oxidative metabolism,
were upregulated by 7.3- ± 3.7-fold and 1.7- ± 0.1-fold, respec-
tively. b-adrenergic signaling plays an important role in the acti-
vation of BAT in response to cold and the regulation of adiposity
(Bachman et al., 2002; Himms-Hagen et al., 1994; Xue et al.,
2007). Both Adrb2 and Adrb3 encoding b-adrenergic receptor
(AR) 2 and 3 were upregulated in RWAT of EE mice (Figure 2A),
while Adrb1 and Adrb3 were downregulated in BAT (Figure 2B).
In contrast to the strong induction of the brown adipocyte gene
program in RWAT, EE suppressed the expression of the white
fat-enriched gene Resn (resistin) and had no impact on adipo-
cyte markers shared by both brown and white fat such as adipo-
genic transcription factor Pparg and adipocyte differentiation
marker Ap2 (Kajimura et al., 2008) (Figure S2A). H&E staining
showed that the RWAT adipocytes of EE mice were smaller
than those in the control mice (Figure 2C). No increase in
apoptosis measured by TUNEL was observed in EE mice (Fig-
ure S2C). Moreover, pockets of cells with the multilocular
morphology characteristic of brown adipocytes (Tsukiyama-
Kohara et al., 2001) were observed in RWAT (Figure 2C). Immu-
nohistochemical staining showed substantially higher levels
of UCP1 protein not only in the cells with typical brown fat
morphology but also in some cells with unilocular white fat
morphology surrounding the pocket of brown fat-like cells (Fig-
ure 2C) (Tsukiyama-Kohara et al., 2001). Western blot showed
marked increase of UCP1, mitochondrial protein HSP60, b3AR,
and PGC-1a levels in RWAT of EE mice (Figure 2D), consistent
with the upregulation of mRNAs. Moreover, the mitochondrial
DNA content of EE RWAT was increased by 2-fold, indicating
enhanced mitochondrial biogenesis (Figure 2E) (Xue et al.,
2007). The other two white fat pads, EWAT (Figure S2D) and
IWAT (Figure S2E), showed fewer genetic changes compared
to RWAT. However, expression of the major adipokine, leptin
(Lep), was highly suppressed in all fat pads (Figures 2A and
2B, Figures S2D and S2E), consistent with the observed sharp
drop in leptin serum levels (64.3% ± 4.0% decrease).
Although efficient in reducing adiposity, voluntary wheel
running for 4 weeks induced different gene expression profiles
in BAT and RWAT compared to EE. Running led to more robust
changes in BAT than EE (Figure 2B). However, less BAT-selec-
tive geneswere induced in RWATof the runningmice (Figure 2A).
We analyzed the RWAT gene expression profiles after 10 weeks
EE, wheel running, and EE without wheel. The standard EE
induced the most robust BAT gene program in RWAT, while
the effects of wheel running and EE without wheel were not
additive (Figure 2F). The molecular signatures in fat induced by
the different environmental interventions suggest distinctive
molecular mechanisms underlying the reduction in adiposity in
response to EE and running.
EE Inhibits DIO
EE induced a ‘‘browning’’ molecular signature in white fat
suggesting that an individual’s interaction with its immediate328 Cell Metabolism 14, 324–338, September 7, 2011 ª2011 Elsevieenvironment could switch a white fat energy storage phenotype
to a brown fat-like energy expenditure phenotype and regulate
adiposity. To test this hypothesis, we investigated whether this
transformation could help animals resist DIO. The chow was
changed to a high-fat diet (HFD, 45% fat, caloric density
4.73 kcal/g) immediately after mice were randomly assigned to
live in EE or control housing. After 4 weeks HFD feeding, the
EE mice gained less weight (71.3% ± 2.7% of control mice
weight gain, Figures 3A and 3D) and remained lean with signifi-
cantly smaller fat pads (p < 0.01, Figures 3B, 3C, and 3E). No
change in food intake was observed (Figure 3F). The body
temperature of EE mice was increased (EE, 34.86C ± 0.20C
versus control, 34.17C ± 0.14C, p = 0.01), suggesting that
elevated energy expenditure, not appetite suppression, led to
the resistance to obesity. Moreover, EE prevented DIO associ-
ated hyperinsulinemia, hyperleptinemia, hyperglycemia, and
dyslipidemia (Figure 3G). Similar to NCD, EE also induced the
BAT molecular signature in DIO mice (Figure 3H), and the levels
of Ppargc1a and Prdm16 were inversely correlated with RWAT
mass (Figures 3I and 3J, p < 0.0001), consistent with a robust
functional effect of these molecular changes.
Long-Term EE Leads to Stronger WAT ‘‘Browning’’
EE of 4 weeks was sufficient to induce WAT ‘‘browning’’ and
resistance to DIO. We then investigated the long-term effect of
EE for 3 months. In EE mice fed on NCD, clear macroscopic
changes in fat pads were visible to the eye, with WAT turning
brown and BAT going even darker (Figure 4A). Brown adipo-
cyte-like cells were found in EWAT of long-term EE mice (Fig-
ure 4B), which was rare in short-term EE mice. The expressions
of brown fat gene markers were further upregulated in EWAT
(Figure 4C, Figure S2D). In contrast to pockets of brown adipo-
cyte-like cells with UCP1 expression found in RWAT of short-
term EE mice, widespread and stronger staining of UCP1 was
observed in long-term EE mice (Figure 4D) associated with
more robust induction of the brown fat gene program (Figure 4E).
For example, Elovl3 was upregulated by 118- ± 53.4-fold after
3 months EE, while it was induced by 27.4- ± 11.2-fold after
4 weeks EE. Despite their different anatomy and function, brown
and white adipocytes are found together in fat depots, and the
WAT/BAT ratio varies with genetic background, sex, age, nutri-
tional status, and environmental conditions supporting the con-
cept of an adipose organ, a multidepot organ consisting of two
tissues displaying considerable plasticity (Frontini and Cinti,
2010). The darker BAT depot observed in long-term EEmay indi-
cate a shift toward brown adipocytes in this depot and/or en-
hanced thermogenic activity that requires further investigation.
EE Enhances WAT Response to Sympathetic
Stimulation
The thermogenic activity of BAT is dependent on intact sympa-
thetic stimulation (Landsberg and Young, 1984), and SNS
stimulation is essential to induce brown fat-like cells in WAT
depots (Cannon and Nedergaard, 2004). BAT is profusely inner-
vated by sympathetic nerve terminals with norepinepherine (NE)
acting via b-ARs. WAT is also innervated, although to a lesser
degree (Slavin and Ballard, 1978; Youngstrom and Bartness,
1995). In mice fed on a NCD, EE led to an approximate 2-fold
increase of NE in WAT (EE 50.0 ± 6.2 pg/mg versus controlr Inc.
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Figure 3. EE Prevents DIO
(A–C) EE mice remained lean compared to control mice when fed on HFD. Scale bar, 1 cm.
(D and E) EE mice had less weight gain (D) and fat mass (E) (n = 10 per group).
(F) Food intake.
(G) Biomarkers in serum.
(H) Gene expression profile in RWAT (n = 5 per group). P values of significance were shown above the bars.
(I and J) Ppargc1a and Prdm16mRNA levels were inversely correlated to RWATweight. Red circles, individual EEmouse; black circles, individual control mouse.
*p < 0.05, **p < 0.01, ***p < 0.001. Data are means ± SEM.
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Hypothalamic-Adipocyte Axis Browns White Fat25.1 ± 3.8 pg/mg, p = 0.012) while no significant increase was
observed in serum, muscle, or BAT. Although NE content per
se is not an index of NE release or sympathetic tone, the coordi-
nated upregulation of b-ARs and NE levels in WAT is consistent
with a change in b-AR signaling and might partially explain the
selective regulation of WAT by EE.
Given the fact that EE led to a marked reduction of adiposity,
we sought to investigate whether this reduction would influence
the animals’ response to cold. Mice of 3 months EE or control
housing were randomized to be maintained at 4C or 22C. After
3 hr acute cold exposure, the EE mice maintained a similar body
temperature as control mice (Figure S3A). We examined the
expression of genes involved in thermogenesis and known to
be activated in response to cold in both BAT and WAT. Both
Dio2 and Ppargc1a expression levels were higher in BAT of EE
mice than control mice at 22C, and their expression was upre-Cell Megulated after cold exposure (Figure S3B). Both genes were also
upregulated in response to cold in controlmiceBAT (Figure S3B).
However, in RWAT of control mice, neither Dio2 nor Ppargc1a
was changed after cold exposure, consistent with the lack of
role for WAT in acute cold response (Figure S3B). In contrast,
Dio2 expression in RWAT of EE mice was 5.43- ± 1.47-fold
higher than control mice at 22C, and its expression levels
were further upregulated by another 2.55- ± 0.22-fold in
response to cold (Figure S3B), suggesting an enhanced molec-
ular response of the EEWAT to acute cold. We further examined
the sensitivity of RWAT of EE mice to NE stimulation at thermo-
neutrality of 30C. Mice of 10 weeks EE were injected with NE
(0.3 mg/kg, s.c.) under anesthesia, and the expression of genes
known to be regulated by NE (Petrovic et al., 2010) was exam-
ined in RWAT 4 hr after NE injection. The low-dose NE failed
to induce significant changes in control RWAT (Figure 4F). Intabolism 14, 324–338, September 7, 2011 ª2011 Elsevier Inc. 329
R
el
at
iv
e 
m
R
N
A 
le
ve
ls
Control
Enrich
Enrich
Enrich
Control
Control
BAT
RWAT
EWAT
R
el
at
iv
e 
m
R
N
A 
le
ve
ls
A
B
C
D
E
Control Enrich
0
2
4
6
8
10
12
Cidea Elovl3 Ppargc1a Prdm16 Ucp1
Control
Enrich
20
40
60
80
100
120
140
160
180
0
1
2
3
4
5
6
7
8
9
10
Cidea Elovl3 Ppargc1a Prdm16 Ucp1
0.019
0.003
0.008
0.057
<0.001
0.003
<0.001
0.027
0.031
0.011
R
el
at
iv
e 
m
R
N
A
R
el
at
iv
e 
m
R
N
A 
R
el
at
iv
e 
m
R
N
A
R
el
at
iv
e 
m
R
N
A
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0
2
4
6
8
10
12
0
2
4
6
8
10
0
10
20
30
40
50
Lep
Dio2
Ppargc1a
Ucp1
F
Control-NE
Enrich+NE
Enrich-NE
Control+NE
Control-NE
Enrich+NE
Enrich-NE
Control+NE
Control-NE
Enrich+NE
Enrich-NE
Control+NE
Control-NE
Enrich+NE
Enrich-NE
Control+NE
A
A
B
C
B B
AB
A
B B
A
A
C BC
B
A
Figure 4. Long-Term EE Leads to Stronger White Fat ‘‘Browning’’
(A) Representatives of BAT, EWAT, and RWAT of control or EE mice after 3 months EE. Scale bar, 1 mm.
(B) H&E staining of EWAT. Scale bar, 20 mm.
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Hypothalamic-Adipocyte Axis Browns White Fatcontrast, RWAT of EE mice was highly responsive to acute low-
dose NE stimulation. Lep which was sharply downregulated in
EE RWAT compared to control mice was further reduced signif-
icantly after NE injection.Ucp1was highly increased by NE stim-
ulation in the EE RWAT (Figure 4F).
We then investigated the role of the global sympathetic drive
in mediating EE regulation of WAT by using the b-blocker
propranolol. Mice receiving propranolol in their drinking water
were randomly assigned to live in EE or control housing for
5 weeks. Propranolol efficiently blocked the molecular features
associated with EE (Figure S3C), suggesting the essential
involvement of the SNS.
Hypothalamic-Adipocyte Axis Mediates EE-Induced
WAT ‘‘Browning’’
We recently report that EE inhibits tumor growth. The anticancer
effect is mediated by hypothalamic brain-derived neurotrophic
factor (BDNF) via activation of the hypothalamic-sympathoneu-
ral-adipocyte (HSA) axis (Cao et al., 2010). Using laser capture
microdissection, we found a consistent upregulation in hypotha-
lamic BDNF in EE mice but not in voluntary running (Cao et al.,
2010). BDNF has recently been identified as a key element in
energy homeostasis (Lyons et al., 1999; Rios et al., 2001; Xu
et al., 2003). Our previous studies have demonstrated that
hypothalamic gene transfer of BDNF leads to marked weight
loss and alleviation of obesity and diabetes (Cao et al., 2009).
Here we further investigated the role of BDNF in EE-induced
‘‘browning’’ of WAT. A rAAV vector expressing the human
BDNF gene was injected to the hypothalamus of DIO mice with
YFP as a control (Cao et al., 2009). The transgene expression
level, location (ARC and VMH), and duration were similar to the
previous studies (Cao et al., 2009, 2010). BDNF overexpression
led to marked weight loss and fat depletion (Figures 5A–5C, Fig-
ure S4A), which reproduced the impact of EE on DIO mice but
to a greater degree (Figure 3E). Similarly, BDNF overexpression
resulted in the EE-associated molecular features, e.g., upregula-
tion of b-ARs and BAT markers in RWAT (Figure 5D). Consistent
with the marked increase in proteins involved in thermogenesis
and mitochondrial function, e.g., UCP1 and HSP60 (Figure 5E,
Figure S4B), all dissected fat depots of BDNF mice showed
substantially higher oxygen consumption ex vivo (Figure S4C).
The BDNF-overexpressing mice showed similar gene expres-
sion changes to EE mice in the whole hypothalamus dissections
(Figure S4D). We further investigated whether b-blockade could
attenuate hypothalamic BDNF’s regulation of WAT. AAV-BDNF
or empty viral vectors were injected to the hypothalamus bilater-
ally. Eight weeks after viral vector injectionwhen both the change
in body weight (BDNF, 3.8 ± 0.8 g versus empty vector, +2.9 ±
0.6 g, p < 0.001) and cumulative food intake (BDNF, 4.77 ±
0.13 g/d versus empty vector, 4.04 ± 0.18 g/d, p = 0.004) had
stabilized, mice were randomly assigned to receive the combi-
nation of the b1 b2 blocker propranolol (2 mg/kg/d for 14 days)(C) Gene expression profile of EWAT (n = 4 per group).
(D) Immunohistochemical staining of UCP1 in RWAT. Scale bar, 200 mm in the u
(E) Gene expression profile of RWAT (n = 4 per group). P values are shown abov
(F) Gene expression profile of RWAT 4 hr after NE injection (n = 4 per group)
means ± SEM. See also Figure S3.
Cell Meand b3 blocker SR59230A (1 mg/kg/d for 14 days) or vehicle
delivered by osmotic minipumps. The b blockade efficiently
attenuated the hypothalamic BDNF-induced gene program in
WAT (Figure S4E).
To further define the role of BDNF, we evaluated several strat-
egies including the use of BDNF heterozygous mice (BDNF+/)
that develop adult-onset obesity associated with hypothalamic
BDNF protein levels approximately 40% lower than wild-type
(Lyons et al., 1999). We observed a substantial increase in the
fat pad mass of BDNF+/ mice before a significant body weight
difference occurred (Figure 6A). Themolecular features of RWAT
in BDNF+/ mice were a complete reversal of that found with EE
or BDNF-overexpressing mice, namely a suppression of b-ARs
and BAT gene program (Figure 6B). However, altered expres-
sion of b-ARs was not observed in muscles of either BDNF+/
mice (Figure S5A) or EE mice (Figure S5B), suggesting a
selective modulation of fat b-AR signaling. We then used a domi-
nant-negative truncated form of the high-affinity BDNF receptor
(TrkB.T1) to specifically inhibit BDNF signaling in the hypothal-
amus of adult mice. Mice receiving rAAV-TrkB.T1 consumed
more food (Figure S5C) and gained more weight than AAV-
YFP controls (Figure S5D). Hypothalamic expression of TrkB.T1
reversed the gene expression changes associated with BDNF
overexpression in the hypothalamus (Figures S5E and S4D),
suggesting efficient inhibition of BDNF signaling. Similar to
DIO mice, RWAT was enlarged in TrkB.T1 mice associated
with the obesity. The molecular signature of RWAT was similar
to BDNF+/ mice (Figure 6B). In order to examine whether the
observed changes in RWAT were simply a result of obesity,
we compared the RWAT molecular features between the DIO
model receiving YFP control virus and TrkB.T1-induced obesity
model. Although both models were identically obese (Figure 6C),
TrkB.T1 led to a further increase of Lep expression above that
of the DIO model (Figure 6D). Thus both global and hypotha-
lamic-specific inhibition of BDNF led to a complete reversal of
the EE-associated molecular features in WAT, indicating
BDNF’s involvement in WAT gene program regulation. Further-
more, we investigated whether BDNF mediated the EE-associ-
ated molecular ‘‘browning’’ of WAT by using microRNA to block
EE-induced BDNF upregulation in hypothalamus (Cao et al.,
2009). We generated AAV vectors expressing a microRNA
targeting Bdnf (miR-Bdnf) and a microRNA targeting a scram-
bled sequence (miR-scr.) (Cao et al., 2010). We injected rAAV
vectors of miR-Bdnf or miR-scr. into the hypothalamus and
then assigned the mice to standard or EE housing for 4 weeks.
MicroRNA knockdown of BDNF led to accelerated weight
gain by approximately 2-fold. In mice receiving miR-scr., the
EE-induced molecular signatures of RWAT were maintained
(Figure 6E). In contrast, miR-Bdnf efficiently inhibited EE-in-
duced hypothalamic BDNF upregulation (Cao et al., 2010) and
completely blocked the molecular changes in WAT associated
with EE (Figure 6E).pper panels, 20 mm in the lower panels.
e the bars.
. Bars not connected by the same letter are significantly different. Data are
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Figure 5. Hypothalamic BDNF Mediates EE-Induced WAT to BAT Transformation
(A) rAAV-mediated gene delivery of BDNF to hypothalamus reproduced EE-associated reduction of adiposity.
(B) Representative images of adipose tissues by MRI.
(C) MRI analysis of abdominal fat and lean mass (n = 4 per group) *p < 0.05. Intra-ab., intra-abdominal; Subcu., subcutaneous.
(D) Gene expression profile of RWAT of BDNF-overexpressing mice and YFP control mice. n = 4 BDNF, n = 5 YFP. P values are shown above the bars.
(E) Western blot of RWAT. Data are means ± SEM. See also Figure S4.
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The development of obesity is influenced by the balance
between BAT andWAT. The proneness to obesity in most rodent
models reportedly correlates with decreased BAT activity, while
the resistance to obesity correlates with increased BAT function
or the emergence of brown adipocyte-like cells or gene expres-
sion in WAT (Chiang et al., 2009; Leonardsson et al., 2004; Pan
et al., 2009; Seale et al., 2011; Tsukiyama-Kohara et al., 2001;
Vegiopoulos et al., 2010). Recent studies demonstrate that adult
humans havemetabolically active BAT which can be activated in
response to cold temperature with the presence of BAT corre-
lating inversely with body fat (Nedergaard et al., 2007; Saito
et al., 2009; van Marken Lichtenbelt et al., 2009; Virtanen et al.,332 Cell Metabolism 14, 324–338, September 7, 2011 ª2011 Elsevie2009; Zingaretti et al., 2009). Furthermore, several histological
studies have reported brown adipocytes dispersed among white
fat in 24% of adult humans biopsies and reaching 50% of cases
with exclusion of patients over 50 years old (Nedergaard et al.,
2007). In addition, studies of human fat cell dynamics show
a high turnover rate of adipocytes with approximately 10% of
fat cells being renewed annually at all adult ages and levels of
body mass index (Spalding et al., 2008). Human white adipo-
cytes from subcutaneous fat tissues can be manipulated
in vitro to develop ‘‘brown’’ characteristics by forced expression
of PGC-1a (Tiraby et al., 2003). These findings further suggest
the therapeutic potential of BAT-oriented strategies to enhance
energy expenditure by facilitating brown adipocyte maintenance
and function, stimulating pre-existing brown precursors, andr Inc.
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Figure 6. BDNF Inhibition Blocks the EE-Induced WAT to BAT Transformation
(A) Increase of adiposity occurred before weight increase in BDNF+/ mice compared to wild-type littermates. n = 4 per group. **p < 0.01, +p < 0.06.
(B) RWAT gene expression profile of BDNF+/ mice compared to wild-type litter mates (n = 4 per group). P values are shown above the bars.
(C) TrkB.T1-expressing mice were equally obese as DIO mice expressing YFP (n = 5 per group).
(D) RWAT gene expression profile of TrkB.T1-expressing mice compared to lean YFP control mice fed with NCD and obese YFP mice fed with HFD (n = 5
per group).
(E) MicroRNA targeting BDNF blocked EE-associated molecular features of RWAT (n = 4 per group; Con, control housing; Enr, EE housing). Bars not connected
by the same letter are significantly different. Data are means ± SEM. See also Figure S5.
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Hypothalamic-Adipocyte Axis Browns White Fatinducing the specific gene program to favor white-to-brown
adipocyte transformation (Enerback, 2010; Frontini and Cinti,
2010; Kajimura et al., 2010). Our data demonstrate that EE
induces a molecular and functional switch from WAT to BAT in
the absence of chronic cold or prolonged pharmacological
b-adrenergic stimulation.Cell MeThe molecular characteristics of EE-inducedWAT ‘‘browning’’
include induction of brown fat molecular switch Prdm16 and
brown fat markers such as Ucp1, Ppragc1a, Elovl3 and Cidea;
suppression of white fat-enriched gene Resn; and no changes
in adipocyte markers shared by both white and brown fat
such as Pparg and Ap2. Recent studies have shown thattabolism 14, 324–338, September 7, 2011 ª2011 Elsevier Inc. 333
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Hypothalamic-Adipocyte Axis Browns White Fatthiazolidinediones (TZDs), a family of insulin sensitizers and
ligands for PPARg, cause WAT browning, but the associated
risk of cardiac and bone side effects and an increase in fat
mass (Farmer, 2008) limit their potential in obesity treatment. In
this context, EE shows advantages over TZDs because it selec-
tively induces genes involved in mitochondrial biogenesis and
oxygen consumption, thereby switching WAT to the BAT pheno-
type without affecting lipogenic genes or the threat of obesity
associated with TZD treatment.
The emergence of brown adipocytes in WAT is under genetic
control, with large differences among inbred strains of mice
(Guerra et al., 1998). C57BL/6 mice, the strain we used in all of
our experiments, respond poorly to sympathetic activation,
probably due to low levels of b-AR expression (Guerra et al.,
1998; Xue et al., 2007). Cold exposure at 5C for 7 days or daily
injection of a b3 agonist for 14 days failed to induce brown adipo-
cytes in RWAT inC57BL/6micewith only sporadic, low induction
of Ucp1 expression (Guerra et al., 1998). In contrast, EE led to
a 27-fold induction of Ucp1 in this strain (Figure 2A), which can
be compared to the 9-fold induction observed in the same strain
of mice acclimated to 5C cold for 4 weeks or the 23-fold induc-
tion after daily injection of b agonist CL316243 for 11–12 days
(Vegiopoulos et al., 2010). Of interest, EE significantly induced
both b2 and b3 AR expression in RWAT (Figure 2A), suggesting
the absence of the desensitization of b ARs after extended expo-
sure to b agonists (Arner, 1992). In addition, an acute low-dose
NE led to downregulation of Lep and upregulation of Ucp1 only
in the EE RWAT, suggesting the enhanced sensitivity to NE stim-
ulation (Figure 4F). Further investigation is required to definitively
clarify whether the increased sympathetic tone to theWAT or the
increased b-AR levels in the WAT enhancing its sensitivity to the
SNS activity, or both, are responsible for the induction of BAT
program.
Adaptive thermogenesis, defined as the regulated production
of heat in response to environmental temperature or diet, is
involved in the development of obesity (Lowell and Spiegelman,
2000). Large interindividual differences in cold-induced (non-
shivering) and diet-induced adaptive thermogenesis exist in
animals and humans. Moreover, the individual metabolic
responses to both cold exposure and overfeeding are related,
suggesting a shared regulatory mechanism (Wijers et al.,
2009). The regulatory mechanisms of cold exposure and sympa-
thetic activation have been extensively investigated in rodents,
which are thought to operate similarly in humans (Nedergaard
et al., 2007). Here we observed a new type of adaptive thermo-
genesis in mice, EE-induced adaptive thermogenesis in
response to a complex environment, which also requires SNS
activation. The b-blocker propranolol administration sufficiently
blocked the EE-induced gene program in WAT (Figure S3C).
Although systemic b blockade affects various tissues, the effi-
cient blockade of molecular signature in WAT at least suggests
an intact b-AR signaling is required for the EE-induced browning.
Selective denervation of each fat pad and electrophysiological
or neurochemical measurement of SNS drive will further define
the role of SNS in this EE-associated adaptive thermogenesis.
The original theories of SNS activation proposed a body-wide
increase in sympathetic outflow (Cannon, 1929). More recent
studies suggest that independent autonomic inputs to individual
organs through distinct autonomic projections permit fine-tuning334 Cell Metabolism 14, 324–338, September 7, 2011 ª2011 Elsevieof metabolism (Anderson et al., 1987). Our data suggest a selec-
tive SNS regulation of WAT by EE with no significant effects on
blood pressure or heart rate (Figure S3D). Studies using the
retrograde neuronal tracer pseudorabies virus (PRV) reveal that
the SNS has a distinct organization in different body compart-
ments. Dual tracing of RWAT and IWAT finds no colocalization
in PVH or amygdala (Kreier et al., 2006). In addition, there is
differential SNS drive among WAT depots as well as between
WAT and BAT after food deprivation, cold exposure, or glucopri-
vation (Brito et al., 2008). For example, RWAT NE turnover
(NETO) increases with glucoprivation and cold, while BAT
NETO is unaffected by glucoprivation or food deprivation. The
mechanisms underlying this fat pad-specific pattern of SNSdrive
remain to be elucidated. We speculate that specific neurons in
the PVH or other parts of the SNS output such as brain stem
(Foster et al., 2010; Grill, 2010) may be activated by specific envi-
ronmental stimulations or physiological conditions and regulate
SNS drive in a fat depot-specific manner, and we are currently
investigating the identity of these neurons in the EE mice.
EE consists of increased dynamic social interactions, frequent
exposure to novel objects, and enhanced physical activity. It is
unlikely that a single variable accounts for all the effects of EE.
Indeed, several lines of evidence suggest exercise alone does
not account for the EE-induced phenotype: (1) EE reduced
adiposity more effectively than wheel running (Figures 1A and
1G), (2) EE showed less physical activity than wheel running,
(3) EE no wheel was able to decrease adiposity (Figure 1G), (4)
EE and wheel-running mice displayed different behavioral adap-
tion in CLAMS (Figure S1A), (5) EE showed increased oxygen
consumption in RWAT whereas wheel running showed an
increase in BAT (Figure 1E), (6) at the level of transcription, EE
induced changes primarily in RWAT while wheel running influ-
enced gene expression mainly in BAT (Figures 2A and 2B), and
(7) EE and wheel running showed two qualitatively distinct
gene expression profiles in PVH (Figure 1H) and whole hypothal-
amus (Figure S1B). However, the removal of running wheels
attenuated WAT browning induced by EE, suggesting that
access to wheels is an important part of the complex environ-
ment provided in EE (Figure 2F). In future studies, we plan to
dissect out which components of EE (sensory, cognitive, motor,
and social stimulation) are essential for WAT browning and how
the brain appraises and responds to different environmental
conditions leading to distinct peripheral changes. Here we
propose one mechanism: the induction of hypothalamic BDNF
expression in response to environmental stimuli leading to
sympathoneural activation (Figure 7). Several lines of evidence
support the role of BDNF: (1) EE induced BDNF expression in
the hypothalamus together with immediate early genes such as
Fos and Junb, markers of neuronal activity (Cao et al., 2010).
The upregulation of BDNF expression observed as early as
2 weeks EE suggests that BDNF is involved early in the regula-
tion of the activity of hypothalamus, a brain structure that
integrates the hypothalamic pituitary axis and the SNS (Ulrich-
Lai and Herman, 2009), monitors and regulates the energetic
state of the body (Ruffin and Nicolaidis, 1999), and modulates
the SNS outflow to both BAT and WAT (Foster et al., 2010;
Perkins et al., 1981). (2) Hypothalamic overexpression of
BDNF mimicked EE-induced ‘‘browning’’ of WAT (Figure 5D).
(3) Inhibition of hypothalamic BDNF function by TrkB.T1 orr Inc.
Figure 7. Mechanism of EE-Induced White Fat
‘‘Browning’’
See the Discussion for details.
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Hypothalamic-Adipocyte Axis Browns White FatBDNF+/ mice led to a complete reversal of the EE-associated
molecular features in WAT (Figures 6B and 6D). (4) Inhibition of
the EE-induced BDNF upregulation in hypothalamus by micro-
RNA blocked the EE-induced brown fatmolecular signature (Fig-
ure 6E). (5) b-AR blockade attenuated EE- or hypothalamic
BDNF overexpression-induced WAT browning (Figures S3C
and S4E).
Our data suggest hypothalamic BDNF expression signals to
increase SNS outflow to WAT. The downstream mediators and
pathways of BDNF remain to be elucidated. BDNF receptor
TrkB is expressed in the PVH, an area involved in the SNS
outflow toWAT (Foster et al., 2010). Both CRH and TRH neurons
in PVH express TrkB (Levin, 2007). Both EE and BDNF overex-
pression led to upregulation of Crh and Trh (Figures S1B and
S4D). In contrast, inhibition of hypothalamic BDNF signaling by
TrkB.T1 downregulated Crh and Trh. Both CRH and TRH have
thermogenic property via the SNS and therefore could mediate
the actions of BDNF (Levin, 2007). However, the upregulation
of Crh was not sustained in PVH with 10 weeks of EE, while
Trh maintained higher levels of expression (Figure 1H). Of
interest, recent evidence suggests that thyroid hormones
increase energy metabolism through a central effect on the
hypothalamus and thereby regulate BAT activity (Cannon and
Nedergaard, 2010; Lopez et al., 2010). No increase in serum
T3, T4, or TSH was observed in the EE mice. However, the
expression of type 2 deiodinase (D2) was induced in WAT by
EE (Figure 2A). D2 activates the prohormone T4 and therebyCell Metabolism 14, 324–increases the local availability of the biologically
active T3, leading to production of extra heat
(Leonard et al., 1983; Watanabe et al., 2006).
Whether TRH is downstream of BDNF in this
central pathway modulating fat remains to be
determined.
The origin of the brown-like cells requires
further investigation. Recent studies have
shown that BAT and skeletal muscle originate
from Myf5+ precursors with Prdm16 controlling
classical brown adipocyte fate (Seale et al.,
2008), and transgenic expression of Prdm16 in
fat tissue induces the brown-like cells in subcu-
taneous WAT but not intraabdominal WAT
depots (Seale et al., 2011). Prdm16 was
modestly but significantly upregulated in WAT
of EE mice (Figure 2A), suggesting possible
recruitment of prebrown adipocyte. However,
at least two possibilities remain: white to brown
transdifferentiation or the activation of ‘‘brite’’
(brown-in-white) adipocytes that are thermo-
genically competent but developmentally and
molecularly distinct from classical brown adipo-
cytes (Petrovic et al., 2010). The adaptive
UCP1-expressing brown-like cells that emergein WAT in response to cold or b-adrenergic stimulation are not
descendent from the same cell lineage as the classical brown
adipocyte but derived predominantly by white to brown adipo-
cyte transdifferentiation (Barbatelli et al., 2010; Timmons et al.,
2007). Further elucidation of the nature of the brown-like cells
induced by EE and the pathways underlying this CNS
regulation of fat phenotype could provide potential therapeutic
strategies for obesity treatment.
In summary, our data demonstrate that EE decreases adi-
posity; increases energy expenditure; causes resistance to
obesity; and induces a genetic, morphological, and functional
transformation from WAT to BAT through a central mechanism
with hypothalamic BDNF as the key mediator linking environ-
mental stimuli, sympathetic outflow, and the ‘‘browning’’ of white
fat and subsequent energy dissipation.
EXPERIMENTAL PROCEDURES
EE Protocol
Male 3-week-old C57Bl/6 mice were housed in EE cage as detailed in the
Supplemental Experimental Procedures. We carried out all mice experi-
ments in compliance with the regulations of the Institutional Animal Ethics
Committees.
Voluntary Running Experiment
Male 3-week-old C57/BL6 mice were housed in cages with free access to
running wheels (Med Associates) as detailed in the Supplemental Experi-
mental Procedures.338, September 7, 2011 ª2011 Elsevier Inc. 335
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Hypothalamic-Adipocyte Axis Browns White FatEE with No Access to Running Wheel Experiment
We randomly assigned 3-week-old C57/BL6 mice to 4 groups: control
housing, EE housing (as described above), EE with no access to running wheel
(remove the wheel from EE cage), and wheel running in regular cage (a wheel
placed in regular mouse cage). The mice were maintained in the respective
housing conditions for 10 weeks.
EE Protocol with HFD
We randomly assigned 20 C57Bl/6 mice to live in EE or control housing as
described above for 4 weeks. We switched the diet from NCD to HFD (45%
fat, caloric density 4.73 kcal/g, Research Diets, Inc.) when EE was initiated.
AAV-Mediated BDNF Overexpression in DIO Mice
We randomly assigned DIO mice (approximately 40 g) to receive AAV-BDNF
or AAV-YFP as detailed in the Supplemental Experimental Procedures. Mice
were maintained on HFD throughout the experiment.
AAV-MicroRNA Experiment
We randomly assigned 7-week-old C57/BL6 mice to receive AAV-miR-Bdnf
(n = 12) or AAV-miR-scr (n = 12) as detailed in the Supplemental Experimental
Procedures. Ten days after surgery, half of the miR-Bdnf mice and miR-scr.
mice were housed in EE housing with the other half of the groups maintained
in standard housing. After 4 weeks of EE housing, we dissected fat pads and
analyzed the gene expression using qRT-PCR.
Statistical Analysis
Data are expressed as mean ± SEM. We used JMP software to analyze
the following: repeated-measures ANOVA for food intake and oxygen
consumption; one-way ANOVA for serum biomarker measurements, body
weight, and adipose tissue weight, body temperature, quantitative RT-PCR
data; and regression for adipose tissue weight-gene expression correlation.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at doi:10.1016/j.cmet.2011.06.020.
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